LRP1 and atherosclerosis: However, although we observe slight reductions in plasma lipids most likely due to clearance by hepatic LDLR-related protein 1 (LRP1), the lack of hepatic APOE-LDLR route for clearance of remnant particles probably prevents better outcomes on the regression of atherosclerosis by CL treatment.